Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.
Skyler
Jay S
JS
University of Miami, Miami, Florida, USA.
Bergenstal
Richard
R
Bonow
Robert O
RO
Buse
John
J
Deedwania
Prakash
P
Gale
Edwin A M
EA
Howard
Barbara V
BV
Kirkman
M Sue
MS
Kosiborod
Mikhail
M
Reaven
Peter
P
Sherwin
Robert S
RS
D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000032:analysis*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D048909:Diabetes Complications / Q000517:prevention & control*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy; D003925:Diabetic Angiopathies / Q000517:prevention & control; D006706:Homeostasis; D006801:Humans; D006943:Hyperglycemia / Q000517:prevention & control*; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012307:Risk Factors; D012680:Sensitivity and Specificity
D001786:Blood Glucose